Mersana Therapeutics

United States

Last Updated May 8, 2025

Company Overview

Company Name

Mersana Therapeutics

Address

United States

About Mersana Therapeutics

Mersana Therapeutics is a biopharmaceutical company based in the United States that focuses on developing innovative antibody-drug conjugates (ADCs) for cancer treatment. The company has proprietary technology platforms, Dolasynthen and Immunosynthen, which allow for customization and optimization of ADCs to address unmet medical needs. Mersana's pipeline includes both cytotoxic and immunostimulatory ADC approaches, with lead candidates such as EMI-LE and XMT-2056 currently in development.

Frequently Asked Questions about Mersana Therapeutics

Social Profiles

Key Decision Makers

Martin Huber President
LinkedIn
Janice Kim Senior Clinical Trial Manager
LinkedIn
Diana Escudero Clinical Trial Manager
LinkedIn